Dr. Ashley Brooke Crew, MD

Dr. Crew practices at Keck Medicine of USC - USC Roski Eye Institute - Ophthalmology - HOPD in Los Angeles, California.

Dr. Crew's NPI, 1942536834, was assigned on October 27, 2009. Dr. Crew graduated from Keck School of Medicine of USC in 2009. Dr. Crew holds California license A115220.

Dr. Crew's primary practice is Keck Medicine of USC - USC Roski Eye Institute - Ophthalmology - HOPD, at 1450 San Pablo St, Los Angeles, CA 90033.

Dr. Crew's primary practice is Keck Medicine of USC - USC Roski Eye Institute - Ophthalmology - HOPD in Los Angeles, California. Dr. Crew is also affiliated with Los Angeles General Medical Center. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Crew to 1 more hospital, 1 group practice or clinic and 1 other site, each named with a free account. Dr. Crew's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Crew practices, 5 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Crew's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Crew is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Crew's licenses on file in 2 states: California and North Carolina.

Dmand AI lists acne, benign or precancerous skin growths, contact dermatitis, itchy rashes, psoriasis, scalp rash, skin cyst and skin discoloration among the conditions Dr. Crew treats.

CMS data shows 507 Medicare services from Dr. Crew across 7 procedure codes in 2024, for 150 Medicare patients. Medicare paid $30,557 for them. Every service was in an office.

CMS counts 150 Medicare patients who saw Dr. Crew in 2024. The largest group is 65 to 74, with 74 patients. 73% of them have high cholesterol, and 72% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Crew's median patient age at 51, with 57% women.

In 2024, Dr. Crew wrote 268 Medicare Part D claims for 86 patients. 90% of them were for generic drugs. CMS names the drug for 148 of them, across 8 drugs with 11 or more claims each, at $7,188 in total drug cost. In 2023, CMS named 50 claims across 3 drugs.

Dr. Crew accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 123 procedures of removal of skin lesions by Dr. Crew, more than 76% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Crew, published from 2016 to 2025. 2016 was the busiest year, with 2. Dr. Crew's most frequent co-authors are Melvin Weiwen Chiu, MD, Jonathan Alan Cotliar, MD and Jennifer Lin Hsiao, MD.

CMS Open Payments shows 41 general payments to Dr. Crew from 7 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $314.

Dr. Crew graduated from Keck School of Medicine of USC in 2009.

Dr. Crew is in network with 9 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.